PAH rs121908296: Understanding This Phenylketonuria Variant
The rs121908296 variant is a specific genetic change in the PAH gene, known as a splice donor variant. It is associated with phenylketonuria (PKU), an autosomal recessive metabolic disorder that affects how the body processes the amino acid phenylalanine.
What each genotype means
Typical PAH enzyme function
This genotype represents the common, functional version of the PAH gene. Individuals with this profile do not carry the specific splice donor variant associated with classic phenylketonuria (PKU) at this location.
This is the most common genotype found in the general population across all ancestries.
Carrier of PAH variant
You carry one copy of the c.1066-11G>A variant, also known as IVS10-11G>A. As this condition is autosomal recessive, carriers typically do not exhibit symptoms of phenylketonuria, but you may wish to discuss reproductive carrier screening with a genetic counselor.
Carried by approximately 0.5% of individuals in European and Middle Eastern ancestries.
Increased risk of PKU
This genotype involves two copies of the c.1066-11G>A variant, which is a known cause of classic severe phenylalanine hydroxylase deficiency. This condition is associated with phenylketonuria (PKU), a metabolic disorder that requires clinical management of phenylalanine intake; please consult with a metabolic specialist or physician for appropriate evaluation.
This genotype is rare in the general population, occurring primarily in individuals who have inherited the variant from both parents.
What is the rs121908296 Variant?
The variant rs121908296, often referred to in clinical literature by its nomenclature c.1066-11G>A, is a change in the DNA sequence of the PAH gene. This specific variant is classified as a splice donor variant. In human genetics, splice sites are critical sequences that tell the cellular machinery where to cut and join segments of messenger RNA (mRNA) during the process of gene expression. When a variant occurs at a splice site, it can disrupt the normal splicing process, potentially leading to the production of a non-functional or unstable protein. Because this variant is located within the PAH gene, it is primarily studied in the context of its impact on the production of the phenylalanine hydroxylase enzyme.
The Role of the PAH Gene
The PAH gene provides the essential instructions for the body to create an enzyme called phenylalanine hydroxylase. This enzyme is responsible for the conversion of phenylalanine, an amino acid found in many protein-rich foods, into another amino acid called tyrosine. Tyrosine is vital for the body, as it is used to produce neurotransmitters, hormones, and melanin, the pigment that gives skin and hair their color. When the PAH enzyme is absent or not functioning correctly, phenylalanine cannot be properly processed and can build up to toxic levels in the blood and brain. This accumulation is the hallmark of phenylketonuria (PKU), a condition that, if left unmanaged, can lead to significant health challenges, including intellectual disability.
Research and Clinical Associations
Research into rs121908296 has identified it as a pathogenic variant associated with phenylketonuria. Because PKU is an autosomal recessive disorder, an individual typically needs to inherit two copies of a pathogenic variant—one from each parent—to manifest the clinical symptoms of the condition. While this variant is recognized in clinical databases as a cause of severe PAH deficiency, the strength of evidence for any single variant can vary based on the specific population and the presence of other genetic factors. It is important to note that the presence of this variant does not automatically equate to a diagnosis of PKU. Clinical diagnosis is based on blood tests measuring phenylalanine levels, not solely on genetic findings. Individuals with concerns about their genetic status or family history should consult with a medical geneticist or a qualified healthcare provider.
Population Frequency and Distribution
The rs121908296 variant is not common in the general population. Current data indicates a frequency of approximately 0.005 in European and Middle Eastern ancestries. Because it is a rare variant, it is most often identified in clinical settings where individuals are being screened for metabolic disorders or during carrier testing. The frequency can vary significantly between different ethnic groups and geographic regions, reflecting the historical distribution of specific genetic mutations. Understanding these frequencies helps researchers and clinicians assess the likelihood of a person being a carrier of a specific PAH variant, though it does not replace the need for individual diagnostic testing when clinical symptoms are present.
Managing Genetic Information
Genetic information regarding variants like rs121908296 is intended for educational purposes and should be interpreted within a clinical context. If you have received information about this variant, it is essential to understand that it is not a medical diagnosis. Genetic testing results should always be discussed with a healthcare professional, such as a genetic counselor, who can explain the implications of the findings in relation to your personal and family health history. You cannot use this information to self-diagnose or make changes to your diet or medical treatment. If you are concerned about PKU or other metabolic conditions, speak with your doctor about appropriate screening tests, which are the gold standard for assessing metabolic health.
How common is this variant?
The rs121908296 variant has a reported frequency of approximately 0.005 in European and Middle Eastern populations.
Frequently asked questions
What is the connection between the PAH gene and PKU?
The PAH gene encodes the enzyme phenylalanine hydroxylase, which breaks down the amino acid phenylalanine. Mutations in this gene can lead to a deficiency of this enzyme, causing phenylalanine to build up to harmful levels, which is the cause of phenylketonuria (PKU).
Is rs121908296 a common genetic variant?
No, this variant is considered rare. It has a population frequency of approximately 0.005 in specific European and Middle Eastern ancestries.
Does having the rs121908296 variant mean I have PKU?
Not necessarily. PKU is an autosomal recessive condition, meaning it usually requires two copies of a pathogenic variant to manifest. A genetic test result should be discussed with a doctor to understand its clinical significance.
How is PKU diagnosed?
PKU is typically diagnosed through blood tests that measure the levels of phenylalanine in the body. Genetic testing can identify the presence of variants in the PAH gene, but it is not the primary method for diagnosing the condition.
Sources & further reading
Educational information only, last refreshed 9/23/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs121908296?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in PAH
Pathogenic missense variant (p.Arg408Trp) associated with phenylketonuria (PKU).
Pathogenic phenylalanine hydroxylase variant conferring risk of phenylketonuria.
A severe pathogenic missense variant (p.Arg408Trp) in the PAH gene associated with phenylketonuria.
Missense variant (c.1222C>T, p.Arg408Trp) that disrupts phenylalanine hydroxylase activity, associated with phenylketonuria.
Splice-site variant (c.1066-11G>A) causing phenylalanine hydroxylase deficiency.
Missense variant (p.Arg408Trp) causing severe classic phenylketonuria (PKU) when inherited bi-allelically due to profound loss of phenylalanine hydroxylase activity.